Shu Cheng

Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma

Jie Xiong, Bowen Cui, Nan Wang et al. · Cancer Cell · 2020 · 228 citations · Full text

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis

Yao‐Hui Huang, Kun Cai, Pengpeng Xu et al. · Signal Transduction and Targeted Therapy · 2021 · 222 citations · Full text

Butyrate-producing Eubacterium rectale suppresses lymphomagenesis by alleviating the TNF-induced TLR4/MyD88/NF-κB axis

Haiyang Lu, Xiaoqiang Xu, Di Fu et al. · Cell Host & Microbe · 2022 · 162 citations

Mucosal Immunology, Microbial Pathogens, Immune Cell Development +13

Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma

Zi-Xun Yan, Li Li, Wen Wang et al. · Clinical Cancer Research · 2019 · 108 citations

Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial

Mu‐Chen Zhang, Shuang Tian, Di Fu et al. · Cancer Cell · 2023 · 98 citations · Full text

Ii Trial, Hematological Malignancy, Lymphoid Neoplasia +14